CONFERENCE INFORMATION

Home > Conference Information

Johannes Bluemel
Johannes Bluemel
Paul-Ehrlich Institut (PEI)
See the Biosketch
Noémie Deneyer
Noémie Deneyer
GlaxoSmithKline Vaccines (GSK)
See the Biosketch
avatar
Blandine De Sainte-Vis
Boehringer Ingelheim
Arifa Khan
Arifa Khan
U.S. Food and Drug Administration (USFDA)
See the Biosketch
avatar
Ivana KNEZEVIC
World Health Organization (WHO)
Laurent Mallet
Laurent Mallet
European Directorate for the Quality of Medicines & HealthCare (EDQM)
See the Biosketch
Pieter Neels
Pieter Neels
International Alliance for Biological Standardization (IABS)
See the Biosketch
Siemon NG
Siemon NG
Notch Therapeutics
See the Biosketch
avatar
Yoji Sato
National Institute of Health Sciences (NIHS)
Johannes Bluemel
Johannes Bluemel
Paul-Ehrlich Institut (PEI)
See the Biosketch
Noémie Deneyer
Noémie Deneyer
GlaxoSmithKline Vaccines (GSK)
See the Biosketch
avatar
Blandine De Sainte-Vis
Boehringer Ingelheim
Ryutaro Hirasawa
Ryutaro Hirasawa
Daiichi Sankyo Co.
See the Biosketch
Kono Ken
Kono Ken
National Institute of Health Sciences (NIHS)
See the Biosketch
Arifa Khan
Arifa Khan
U.S. Food and Drug Administration (USFDA)
See the Biosketch
avatar
Ivana KNEZEVIC
World Health Organization (WHO)
Laurent Mallet
Laurent Mallet
European Directorate for the Quality of Medicines & HealthCare (EDQM)
See the Biosketch
Siemon NG
Siemon NG
Notch Therapeutics
See the Biosketch
Access to meeting’s slides is given to meeting’s participants for a period of 4 weeks after the meeting.
Login and password are sent by email to participants right after the meeting.
Afterwards the slides are only accessible to IABS members, using their Member Login and Password.

The International Alliance for Biological Standardization (IABS) is an independent, non-profit scientific Alliance, governed by Articles 60-79 of the Swiss Civil code and by its Constitution. Its office is located in Geneva (Switzerland). IABS has members in over 50 countries.

OFFICERS

MISSION

The mission of the Alliance which is related to the scientific and medical advancement of Biologicals, includes :

  • To host conferences and workshops, facilitate communication, and develop consensus on key contemporary issues related to biologicals among those who discover, develop, produce and regulate biological products for human and animal health
  • To foster evidence-based Science as the standard for improving and ensuring the quality and the safety of biological products
  • To share scientific advancements and innovative regulatory solutions through our journal “Biologicals”.

PUBLICATIONS

Reports and proceedings of IABS conferences and workshops appear in its journal Biologicals, published by Elsevier.

MEMBERSHIP BENEFITS

  • Affiliations with a global community of recognized experts
  • Exclusive access to archived information from scientific events (library of speaker presentations, conclusions and recommendations)
  • Reduced fees for a subscription to the journal Biologicals
  • Voting rights for matters discussed during the Biennial IABS General Assembly (Elections, Constitutional changes)

For more information on how to become a member of IABS, please visit: www.iabs.org